CCR4 is critically involved in effective antitumor immunity in mice bearing intradermal B16 melanoma.


CCR4 is a major chemokine receptor expressed by Treg cells and Th17 cells. While Treg cells are known to suppress antitumor immunity, Th17 cells have recently been shown to enhance the induction of antitumor cytotoxic T lymphocytes. Here, CCR4-deficient mice displayed enhanced tumor growth upon intradermal inoculation of B16-F10 melanoma cells. In CCR4… (More)
DOI: 10.1016/j.canlet.2016.04.039